Product NDC: | 0013-2576 |
Proprietary Name: | Idamycin PFS |
Non Proprietary Name: | idarubicin hydrochloride |
Active Ingredient(s): | 1 mg/mL & nbsp; idarubicin hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0013-2576 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050734 |
Marketing Category: | NDA |
Start Marketing Date: | 19970217 |
Package NDC: | 0013-2576-91 |
Package Description: | 5 mL in 1 VIAL, SINGLE-USE (0013-2576-91) |
NDC Code | 0013-2576-91 |
Proprietary Name | Idamycin PFS |
Package Description | 5 mL in 1 VIAL, SINGLE-USE (0013-2576-91) |
Product NDC | 0013-2576 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | idarubicin hydrochloride |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19970217 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | IDARUBICIN HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |